Study at a glance
What is the difference between a vitamin D deficiency cut-off and a target?
This review asks why a vitamin D deficiency cut-off and a desired blood-level target need different evidence. A cut-off identifies a range associated with increased risk. A target implies that aiming for a particular level provides a benefit. The usual blood measurement is 25-hydroxyvitamin D, which reflects vitamin D supply.
Do studies show one ideal vitamin D blood level?
Studies of parathyroid hormone, which helps regulate calcium, have not identified one ideal vitamin D level for everyone. In a one-year trial of women after menopause, supplements substantially raised blood vitamin D levels. Calcium absorption increased only modestly. This does not show that vitamin D is unimportant; it limits the claim that higher blood levels always improve calcium absorption.
What did the 2024 vitamin D guideline conclude?
The Endocrine Society’s 2024 prevention guideline found that trials did not establish blood-level cut-offs predicting specific supplement benefits in generally healthy populations. It stopped endorsing its earlier universal target for those populations. That does not prove higher targets are harmful or could never be useful in a particular clinical situation.
Does avoiding deficiency mean higher vitamin D levels are better?
Severe vitamin D deficiency remains a concern for bone and mineral health. However, evidence of harm at low levels does not by itself prove benefit from aiming much higher. Population requirements also do not define every individual’s ideal level. Any target needs evidence for its particular purpose, with laboratory uncertainty and individual differences considered.
Read the full article below ↓A vitamin D deficiency threshold and a functional target range are not the same scientific object. A deficiency threshold attempts to identify a concentration below which the probability of inadequate vitamin D-dependent physiology or clinically important skeletal consequences becomes unacceptable. A functional target asks a different question: whether maintaining 25-hydroxyvitamin D [25(OH)D] at a higher concentration produces more favourable physiological performance or clinical outcomes. Confusing those questions can make a higher proposed target appear to be the inevitable extension of a lower deficiency boundary when the underlying evidence may not support that inference. This distinction develops the broader framework in Vitamin D Thresholds vs Targets. For a shorter version of this evidence review, see Physiological Distinction Between Vitamin D Deficiency Thresholds and Functional Target Ranges: Study Summary.
A deficiency threshold answers a risk question
Vitamin D physiology operates along a continuum rather than through a simple biological switch. Circulating 25(OH)D is the principal marker used to estimate vitamin D supply, but the consequences of progressively lower concentrations depend on several interacting processes: intestinal calcium absorption, parathyroid hormone (PTH) secretion, renal conservation of calcium, bone turnover, active-hormone production, dietary calcium intake and individual biological variation. A numerical deficiency threshold therefore does not mean that every person immediately changes physiological state at exactly that concentration. It represents an evidence-based boundary intended to identify a region in which risk becomes sufficiently important for a defined purpose.
This is why Vitamin D Deficiency Definitions cannot be interpreted simply as a collection of interchangeable numbers. Different organisations may choose thresholds according to different endpoints, populations and evidential standards. A threshold designed to protect against rickets, osteomalacia or clearly impaired mineral metabolism does not automatically identify the concentration that maximises every possible biological action of vitamin D.
Population adequacy is different from individual optimisation
The Institute of Medicine framework illustrates this distinction. Its dietary reference model integrated skeletal outcomes and population requirements and concluded that approximately 16 ng/mL (40 nmol/L) of 25(OH)D would meet the needs of roughly half the population, while at least 20 ng/mL (50 nmol/L) would meet the requirements of at least 97.5% of the population under the model used. Those values were not claims that 20 ng/mL is a universal physiological optimum for every person or every organ system. They were population-level adequacy estimates linked to the endpoints considered sufficiently established for setting dietary reference intakes.
That difference matters when interpreting Population Reference Ranges Explained. Population adequacy, laboratory reference intervals, diagnostic thresholds and individual therapeutic targets are conceptually related but not interchangeable. A population value intended to cover nearly everyone does not prove that every individual below it is clinically deficient, nor does it prove that every concentration above it is equally desirable for every possible biological outcome.
PTH provides useful physiology but not a universal target
PTH has often been used to argue for a higher vitamin D target. As 25(OH)D falls, reduced calcium absorption and altered calcium economy can stimulate PTH secretion. This makes the inverse relationship between 25(OH)D and PTH biologically informative. If PTH consistently plateaued at one precise 25(OH)D concentration across populations, that point might appear to provide a convenient functional target.
The evidence is more complicated. Studies have identified different apparent inflection points, while others have found a smoother inverse relationship without one universal plateau. PTH is influenced by age, renal function, body composition, calcium intake, magnesium, phosphate, assay methodology and other factors. A large 2023 analysis in an apparently healthy northern Chinese population identified one point above which PTH largely plateaued and another below which it rose more steeply, but those values cannot automatically be exported to every population.
This variability is central to Why Vitamin D Insufficiency Is Not a Universal Cut-Off. A physiological relationship can be real without yielding one globally valid numerical target. The presence of compensatory physiology does not mean that one PTH-derived number is necessarily the concentration that everyone should seek.
Calcium absorption does not establish a simple higher optimum
Intestinal calcium absorption is another plausible functional endpoint. Severe vitamin D depletion can impair calcium handling, so it is reasonable to ask whether progressively higher 25(OH)D concentrations continue to improve absorption. Earlier observational work contributed to the idea that calcium absorption might be greater above approximately 30 ng/mL than near 20 ng/mL.
Randomised evidence has made that interpretation less straightforward. Gallagher and colleagues studied postmenopausal women with baseline 25(OH)D below 20 ng/mL and randomised them to placebo or multiple vitamin D3 doses for one year while maintaining calcium intake. Serum 25(OH)D rose substantially across treatment groups, but calcium absorption changed only modestly. Across a broad 25(OH)D range, the investigators found no clear threshold at which calcium absorption suddenly became inadequate and concluded that the increase produced by higher vitamin D exposure was small.
This does not mean vitamin D is irrelevant to calcium physiology. Severe deficiency can clearly compromise mineral metabolism. It means that evidence for preventing deficiency cannot simply be extrapolated into evidence that calcium absorption is continuously improved by pursuing a substantially higher target. The distinction between a lower boundary that protects normal mineral physiology and a higher concentration proposed as “optimal” must be demonstrated rather than assumed.
Insufficiency occupies the uncertain space between deficiency and target claims
The term insufficiency became influential partly because it offered a name for concentrations above overt deficiency but below proposed higher targets. That intermediate concept is physiologically plausible: homeostatic compensation can occur before severe deficiency is reached, and different people may show differing PTH or mineral responses at the same measured concentration. Vitamin D Insufficiency Explained addresses why this zone may carry biological meaning without behaving like a discrete disease category.
The difficulty arises when an intermediate state is converted into a fixed universal target. If a concentration of 20 ng/mL is adequate for the great majority of people according to one population skeletal model, while another framework proposes 30 ng/mL as a desirable concentration, the difference cannot be resolved by calling everything between 20 and 30 ng/mL “insufficient.” The higher boundary needs its own evidence demonstrating why that target is biologically or clinically preferable for the population and endpoint being considered.
This is also why Vitamin D Insufficiency: Physiology, Thresholds and Interpretation: Evidence Synthesis treats insufficiency as an interpretive category rather than as a universally fixed numerical band.
A target requires outcome-specific evidence
A functional target is scientifically stronger than a deficiency boundary because it implies that aiming for a particular higher range provides meaningful advantage. That advantage could theoretically be defined by lower PTH, improved calcium absorption, better bone outcomes, lower fracture risk, improved immune function or another clinically important endpoint. But different endpoints need not share the same relationship with 25(OH)D.
This distinction became particularly visible in the Endocrine Society’s 2024 guideline. Its panel evaluated randomised evidence for disease prevention in generally healthy populations and concluded that available trial data did not permit identification of outcome-specific 25(OH)D thresholds that reliably predicted benefit from supplementation. The Society consequently stopped endorsing its previous 30 ng/mL definition of sufficiency for generally healthy people. That change does not prove that 30 ng/mL is harmful or that no higher target could ever be justified in a particular clinical context. It shows that the evidential basis for a universal higher target is different from the evidential basis for recognising low vitamin D status.
In other words, the absence of proof for one universal target does not erase deficiency biology. Conversely, the existence of deficiency biology does not prove a universal optimum. These are separate propositions.
Measurement uncertainty weakens false precision
Any attempt to treat one numerical value as a universal target must also contend with measurement variation. Assay differences have historically shifted measured 25(OH)D concentrations enough to alter the apparent prevalence of deficiency or insufficiency. Standardisation programmes have shown that re-standardising population data can move mean concentrations in either direction and materially change classification.
This is not an argument that 25(OH)D testing is useless. It remains the central biochemical measure of vitamin D status. It is an argument against pretending that a single value such as 29.9 versus 30.1 ng/mL represents a sharp biological transition when analytical uncertainty and continuous physiology make that degree of precision scientifically implausible.
The same concern underlies the distinction developed in Vitamin D Sufficiency Explained: sufficiency must be interpreted in relation to the endpoint, population and evidential framework rather than as a magical concentration above which every vitamin D-dependent process is maximised.
Thresholds and targets can both be legitimate when their purpose is explicit
The scientifically useful position is not that thresholds are wrong or targets are wrong. Both can be legitimate if the question they answer is explicit. A deficiency threshold may identify concentrations associated with clearly increased risk of rickets, osteomalacia, impaired calcium economy or another defined outcome. A treatment target may be appropriate in a particular disease, population or therapeutic protocol if evidence shows that aiming for that range improves outcomes or safely achieves a specific clinical objective.
The problem begins when those categories are merged. A nutritional adequacy threshold becomes a universal diagnostic threshold; a diagnostic threshold becomes an individual target; an observational association becomes an optimisation claim; or a population distribution becomes a prescription for every person. Distinguishing Vitamin D Insufficiency from Deficiency and Sufficiency: Full Study shows why these labels require separate evidential interpretation even though they occupy the same numerical continuum.
The practical interpretation
A low 25(OH)D concentration can be clinically meaningful without implying that every person should pursue a substantially higher numerical target. The lower end of the vitamin D continuum is supported by increasingly consistent evidence of impaired skeletal and mineral physiology as depletion becomes severe. Above that region, compensatory physiology, individual variation, endpoint choice and measurement uncertainty become progressively more important.
The appropriate interpretation is therefore conditional. Ask first what the number is intended to represent. Is it a threshold for preventing overt deficiency? A population adequacy value? A laboratory classification? A treatment threshold? A physiological optimisation hypothesis? Or an outcome-specific therapeutic target? Only after that question is answered can the number itself be interpreted responsibly.
A deficiency threshold marks an evidence-based boundary of concern. A functional target requires additional evidence that aiming higher produces additional meaningful benefit. Treating the second as if it automatically follows from the first is the central conceptual error.
Scientific sources
Ross AC, Manson JE, Abrams SA, et al. The 2011 Report on Dietary Reference Intakes for Calcium and Vitamin D from the Institute of Medicine: What Clinicians Need to Know. Journal of Clinical Endocrinology & Metabolism. 2011;96(1):53-58. PMID: 21118827. PMCID: PMC3046611. DOI: 10.1210/jc.2010-2704.
Gallagher JC, Yalamanchili V, Smith LM. The Effect of Vitamin D on Calcium Absorption in Older Women. Journal of Clinical Endocrinology & Metabolism. 2012;97(10):3550-3556. PMID: 22855333. PMCID: PMC3462946. DOI: 10.1210/jc.2012-2020.
Sempos CT, Heijboer AC, Bikle DD, et al. Vitamin D assays and the definition of hypovitaminosis D: results from the First International Conference on Controversies in Vitamin D. British Journal of Clinical Pharmacology. 2018;84(10):2194-2207. DOI: 10.1111/bcp.13652.
Demay MB, Pittas AG, Bikle DD, et al. Vitamin D for the Prevention of Disease: An Endocrine Society Clinical Practice Guideline. Journal of Clinical Endocrinology & Metabolism. 2024;109(8):1907-1947. DOI: 10.1210/clinem/dgae290.
McCartney CR, McDonnell ME, Corrigan MD, Lash RW. Vitamin D Insufficiency and Epistemic Humility: An Endocrine Society Guideline Communication. Journal of Clinical Endocrinology & Metabolism. 2024;109(8):1948-1954. DOI: 10.1210/clinem/dgae322.
Related reading
Physiological Distinction Between Vitamin D Deficiency Thresholds and Functional Target Ranges: Study Summary
A concise evidence summary explaining why vitamin D deficiency thresholds and functional target ranges represent different physiological and interpretive concepts.
Read more →Threshold of 25(OH)D and consequently adjusted parathyroid hormone reference intervals: data mining for relationship between vitamin D and parathyroid hormone
By recruiting reference population, we aimed to (1): estimate the 25(OH)D threshold that maximally inhibits the PTH, which can be defined as the cutoff value for vitamin D sufficiency; (2) establish the PTH reference interval (RI) in population with sufficient vitamin D.
Original paper ↗Read more →Targets for parathyroid hormone in secondary hyperparathyroidism: is a “one-size-fits-all” approach appropriate? A prospective incident cohort study
Recommendations for secondary hyperparathyroidism (SHPT) consider that a “one-size-fits-all” target enables efficacy of care.
Original paper ↗Read more →Higher Proportion of Non-1-84 PTH Fragments in Peritoneal Dialysis Patients Compared to Hemodialysis Patients Using Solutions Containing 1.75 mmol/l Calcium
The prevalence of low: turnover bone disease (LTBD) in peritoneal dialysis (PD) patients is higher than in hemodialysis (HD) patients.
Original paper ↗Read more →A parathyroid hormone/salt-inducible kinase signaling axis controls renal vitamin D activation and organismal calcium homeostasis
The renal actions of parathyroid hormone (PTH) promote 1,25-vitamin D generation; however, the signaling mechanisms that control PTH-dependent vitamin D activation remain unknown.
Original paper ↗Read more →Arterial Structure and Function in Mild Primary Hyperparathyroidism Is Not Directly Related to Parathyroid Hormone, Calcium, or Vitamin D
We evaluated the possible vascular effects of these risk factors in patients with mild PHPT by using standard methods and new imaging techniques.
Original paper ↗Read more →Association between 25-Hydroxyvitamin D, Parathyroid Hormone, Vitamin D and Calcium Intake, and Bone Density in Healthy Adult Women: A Cross-Sectional Analysis from the D-SOL Study
This cross-sectional analysis aimed to investigate the associations of 25(OH)D and plasma PTH concentrations with bone parameters, and potential confounders, in women living in a high (England) or low (Brazil) latitude country.
Original paper ↗Read more →Associations of Vitamin D Deficiency, Parathyroid hormone, Calcium, and Phosphorus with Perinatal Adverse Outcomes. A Prospective Cohort Study
We aimed to evaluate the association of vitamin D deficiency during early pregnancy with preterm birth.
Original paper ↗Read more →Genetic association of serum calcium, phosphate, vitamin D, parathyroid hormone, and FGF23 with the risk of aortic stenosis
However, evidence of the causal role of mineral metabolism in CAVS is still lacking.
Original paper ↗Read more →Interactions between Vitamin D Status, Calcium Intake and Parathyroid Hormone Concentrations in Healthy White-Skinned Pregnant Women at Northern Latitude
Little explored in pregnancy, we aimed to examine the relative importance of serum 25-hydroxyvitamin D (25(OH)D) and calcium intake on parathyroid hormone (PTH) concentrations in healthy white-skinned pregnant women.
Original paper ↗Read more →Parathyroid hormone in Sri Lankan pregnant women: Vitamin D and other determinants
We aimed to describe the serum parathyroid hormone (PTH) and its determinants in Sri Lankan pregnant women in a community setting.
Original paper ↗Read more →Postprandial metabolic responses of serum calcium, parathyroid hormone and C-telopeptide of type I collagen to three doses of calcium delivered in milk
The present study investigated Ca absorption patterns with increasing levels of fortification in milk, and the response to one dose of a Ca salt.
Original paper ↗Read more →R990G Polymorphism of Calcium Sensing Receptor Gene Is Associated with High Parathyroid Hormone Levels in Subjects with Vitamin D Deficiency: A Cross-Sectional Study
Single nucleotide polymorphisms (SNPs), R990G and A986S of the calcium sensing receptor (CaSR) gene, are shown to influence response of parathyroid hormone (PTH) in subjects with optimal vitamin D levels.
Original paper ↗Read more →Relationship Between Total 25-Hydroxyvitamin D and Parathyroid Hormone Concentrations During Early Gestation in Indian Women
The inverse relationship between 25(OH)D and parathyroid hormone (PTH) concentrations was examined to define the breakpoint at which PTH was maximally suppressed using a segmented regression analysis.
Original paper ↗Read more →Seasonal variation and correlation analysis of vitamin D and parathyroid hormone in Hangzhou, Southeast China
This study aimed to describe the 25‐hydroxyvitamin D (25(OH)D) and parathyroid hormone (PTH) status of Southeast Chinese individuals influenced by season.
Original paper ↗Read more →The Influence of Different Cholecalciferol Supplementation Regimes on 25(OH) Cholecalciferol, Calcium and Parathyroid Hormone after Bariatric Surgery
Background and objectives: Vitamin D is an essential vitamin that plays a key role in maintaining physiological calcium balance, and is also a pivotal element in the formation of bone structure.
Original paper ↗Read more →The relationship between serum 25-hydroxyvitamin D and parathyroid hormone concentration in assessing vitamin D deficiency in pet rabbits
Thus, this study aimed to identify the breakpoint in the 25-hydroxyvitamin D concentration indicating a significant change in the parathyroid hormone concentration in 139 pet rabbits.
Original paper ↗Read more →The Role of Calcium, 25-Hydroxyvitamin D, and Parathyroid Hormone in Irritable Bowel Syndrome: A Bidirectional Two-Sample Mendelian Randomization Study
Therefore, we aimed to explore the bidirectional causal effects among serum calcium, Vit-D, PTH, and IBS at the genetic level by a two-sample Mendelian randomization (MR) analysis of the datasets from IEU OpenGWAS database.
Original paper ↗Read more →Diverse Effects of Combinations of Maternal-Neonatal VDR Polymorphisms and 25-Hydroxyvitamin D Concentrations on Neonatal Birth Anthropometry: Functional Phenocopy Variability Dependence, Highlights the Need for Targeted Maternal 25-Hydroxyvitamin D Cut-Offs during Pregnancy
The aim of this study was to evaluate the combined effect of maternal and neonatal VDR polymorphisms (ApaI, TaqI, BsmI, FokI, Tru9I) and different maternal and neonatal 25(OH)D cut-offs on neonatal birth anthropometry.
Original paper ↗Read more →Why Vitamin D Insufficiency Is Not a Universal Cut-Off
Learn why vitamin D insufficiency has no universal numerical cut-off and how physiology, guideline purpose, population thresholds and measurement variability affect interpretation.Page type: Context.
Read more →Serum 25-hydroxyvitamin D and parathyroid hormone in relation to plasma B-type natriuretic peptide: the Hoorn Study
Therefore, we investigated whether lower 25-hydroxyvitamin D (25(OH)D) and higher PTH are cross sectionally and after 8 years of follow-up associated with higher B-type natriuretic peptide (BNP) levels in older men and women.
Original paper ↗Read more →Original sources
n Between Vitamin D Deficiency Thresholds and Functional Target Ranges - Study Summary
A vitamin D deficiency threshold and a functional target range are not the same scientific object.
Publication details
A vitamin D deficiency threshold and a functional target range are not the same scientific object. A deficiency threshold attempts to identify a concentration below which the probability of inadequate vitamin D-dependent physiology or clinically important skeletal consequences becomes unacceptable. A functional target asks a different question: whether maintaining 25-hydroxyvitamin D [25(OH)D] at a higher concentration produces more favourable physiological performance or clinical outcomes. Confusing those questions can make a higher proposed target appear to be the inevitable extension of a lower deficiency boundary when the underlying evidence may not support that inference. This distinction develops the broader framework in Vitamin D Thresholds vs Targets. For a shorter version of this evidence review, see Physiological Distinction Between Vitamin D Deficiency Thresholds and Functional Target Ranges: Study Summary.
The 2011 Report on Dietary Reference Intakes for Calcium and Vitamin D from the Institute of Medicine: What Clinicians Need to Know
Published in Journal of Clinical Endocrinology & Metabolism (2011).
Publication details
Ross AC, Manson JE, Abrams SA, et al. The 2011 Report on Dietary Reference Intakes for Calcium and Vitamin D from the Institute of Medicine: What Clinicians Need to Know. Journal of Clinical Endocrinology & Metabolism. 2011;96(1):53-58. PMID: 21118827. PMCID: PMC3046611. DOI: 10.1210/jc.2010-2704.
The Effect of Vitamin D on Calcium Absorption in Older Women
Published in Journal of Clinical Endocrinology & Metabolism (2012).
Publication details
Gallagher JC, Yalamanchili V, Smith LM. The Effect of Vitamin D on Calcium Absorption in Older Women. Journal of Clinical Endocrinology & Metabolism. 2012;97(10):3550-3556. PMID: 22855333. PMCID: PMC3462946. DOI: 10.1210/jc.2012-2020.
Vitamin D assays and the definition of hypovitaminosis D: results from the First International Conference on Controversies in Vitamin D
Published in British Journal of Clinical Pharmacology (2018).
Publication details
Sempos CT, Heijboer AC, Bikle DD, et al. Vitamin D assays and the definition of hypovitaminosis D: results from the First International Conference on Controversies in Vitamin D. British Journal of Clinical Pharmacology. 2018;84(10):2194-2207. DOI: 10.1111/bcp.13652.
Vitamin D for the Prevention of Disease: An Endocrine Society Clinical Practice Guideline
Published in Journal of Clinical Endocrinology & Metabolism (2024).
Publication details
Demay MB, Pittas AG, Bikle DD, et al. Vitamin D for the Prevention of Disease: An Endocrine Society Clinical Practice Guideline. Journal of Clinical Endocrinology & Metabolism. 2024;109(8):1907-1947. DOI: 10.1210/clinem/dgae290.
Vitamin D Insufficiency and Epistemic Humility: An Endocrine Society Guideline Communication
Published in Journal of Clinical Endocrinology & Metabolism (2024).
Publication details
McCartney CR, McDonnell ME, Corrigan MD, Lash RW. Vitamin D Insufficiency and Epistemic Humility: An Endocrine Society Guideline Communication. Journal of Clinical Endocrinology & Metabolism. 2024;109(8):1948-1954. DOI: 10.1210/clinem/dgae322.